| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SKELETAL MUSCLE AND EXERCISE |
-tropomyosin mutation on regulation of muscle contraction in single human muscle fibres
1 Department of Clinical Neurophysiology, Uppsala University Hospital, Sweden
2 Department of Neurology, Qilu Hospital, Shandong University, China
3 Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
4 Department of Neuropaediatrics, Uppsala University Children's Hospital, Sweden
5 The Queen Silvia Children's Hospital, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
6 Center for Development and Health Genetics, Pennsylvania State University, University Park, PA, USA
A novel R133W 
-tropomyosin (-Tm) mutation, associated with muscle weakness and distal limb deformities, has recently been identified in a woman and her daughter. The muscle weakness was not accompanied by progressive muscle wasting or histopathological abnormalities in tibialis anterior muscle biopsy specimens. The aim of the present study was to explore the mechanisms underlying the impaired muscle function in patients with the -Tm mutation. Maximum force normalized to fibre cross-sectional area (specific force, SF), maximum velocity of unloaded shortening (V0), apparent rate constant of force redevelopment (ktr) and force–pCa relationship were evaluated in single chemically skinned muscle fibres from the two patients carrying the -Tm mutation and from healthy control subjects. Significant differences in regulation of muscle contraction were observed in the type I fibres: a lower SF (P < 0.05) and ktr (P < 0.01), and a faster V0 (P < 0.05). The force–pCa relationship did not differ between patient and control fibres, indicating an unaltered Ca2+ activation of contractile proteins. Collectively, these results indicate a slower cross-bridge attachment rate and a faster detachment rate caused by the R133W -Tm mutation. It is suggested that the R133W -Tm mutation induces alteration in myosin–actin kinetics causing a reduced number of myosin molecules in the strong actin-binding state, resulting in overall muscle weakness in the absence of muscle wasting.
(Received 2 February 2007; Corresponding author Julien Ochala: Department of Neuroscience, Clinical Neurophysiology, University Hospital, Entrance 85, 3rd floor, SE-751 85 Uppsala, Sweden. Email: julien.ochala{at}neurofys.uu.se
Related Article
J. Physiol. 2007 581: 889.
This article has been cited by other articles:
|
|
 |
|
  M. Ohlsson, S. Quijano-Roy, N. Darin, G. Brochier, E. Lacene, D. Avila-Smirnow, M. Fardeau, A. Oldfors, and H. Tajsharghi New morphologic and genetic findings in cap disease associated with {beta}-tropomyosin (TPM2) mutations Neurology, December 2, 2008; 71(23): 1896 - 1901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tajsharghi, E. Kimber, A.-K. Kroksmark, R. Jerre, M. Tulinius, and A. Oldfors Embryonic Myosin Heavy-Chain Mutations Cause Distal Arthrogryposis and Developmental Myosin Myopathy That Persists Postnatally Arch Neurol, August 1, 2008; 65(8): 1083 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ochala, M. Li, M. Ohlsson, A. Oldfors, and L. Larsson Defective regulation of contractile function in muscle fibres carrying an E41K {beta}-tropomyosin mutation J. Physiol., June 15, 2008; 586(12): 2993 - 3004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Chase Tropomyosin in the groove? Molecular insights into an inherited myopathy J. Physiol., June 15, 2007; 581(3): 889 - 889. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
